Tesamorelin has real human trial and label data behind its side-effect profile. The most common reactions on the label are arthralgia (joint pain), injection-site reactions, peripheral edema, and myalgia. In the pivotal trials it was generally well tolerated over months of use.[1][2]
Reviewed for accuracy · Last reviewed July 7, 2026Because tesamorelin works by raising the body's own growth hormone, the label flags elevated IGF-1, fluid retention or edema, and glucose intolerance as considerations, along with malignancy considerations specific to the HIV population studied. One trial noted no significant glucose perturbation, so the picture is nuanced rather than uniformly reassuring or alarming.
Joint pain and mild swelling are the effects most often reported. Persistent swelling that does not settle, or signs of an allergic reaction, are reasons to seek medical attention rather than wait it out.
This page is an independent educational reference and is not medical advice. Talk to a doctor before starting any compound.